Skip to content

Efficacy Study of the Medical Device TRP Snorless™ in the Treatment of Snoring

Efficacy Study of the Medical Device TRP Snorless™ in the Treatment of Snoring

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03222193
Acronym
SCORED
Enrollment
35
Registered
2017-07-19
Start date
2017-06-16
Completion date
2019-06-15
Last updated
2018-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Snoring

Keywords

Medical device, Retraining, Snoring, TRP, Tongue

Brief summary

The Tongue Right Positioner (TRP Snorless™) is a medical device designed to restore physiological tongue positions when functioning or at rest and increase tongue muscles tone. Patient wears TRP Snorless™ daily at least 5 hours during night. Published data suggested that TRP Snorless™ increases oropharynx diameter and nasal patency, favouring airflow in upper airways. Independently of patient's adherence to daily myofascial exercises, the TRP Snorless™ treatment should increase tongue muscles' tone and decrease the risk of snoring during sleep.

Interventions

DEVICETRP

3 months of TRP tongue retraining

Sponsors

Tongue Laboratory
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Man or woman ≥ 18 years and ≤ 65 years at the time of signing informed consent * Listed as continuous snorer (snoring at least 4 nights/week) * Answer Extremely loud or very loud to question 1 of SBPS at screening * Answer very severe or severe to question 2 of SBPS at screening * Answer extremely or quite a bit to question 3 of SBPS at screening * Dated and signed informed consent * BMI ≤ 35

Exclusion criteria

* Severe Mandibular retrognathia and micrognathia * Narrow and deep palate (less than 3 cm wide) * Lack of three consecutive teeth in the area of (15-16-17-18) or (25-26-27-28). * Lingual or labial short frenulum (the tongue cannot reach the upper incisors when mouth can be opened for two fingers) * Intolerable gag reflex * Known nasal septal deviation * Neck circumference \> 46 cm * Patient currently treated for OSA * Patient with AHI≥30 events/hour or with AHI\>15 and (SFI) Sleep Fragmentation Index \> 20 * Patient currently treated for central sleep apnoea * Addiction to alcoholic beverages (5 drinks per day per NIAAA) * Under constant pharmacological treatment for depression, anxiety, chronic pain, insomnia * Hypertrophy of tonsils * Macroglossia * Hypertrophy of uvula * Primary gastroesophageal reflux * Any other pathology preventing subject from complying with the protocol * Subject with recent oropharyngeal surgery or likely during the study * Mental inability, unwillingness or language barrier precluding adequate understanding of or compliance with study procedures * Pregnancy * Patient with severe Chronic Obstructive Pulmonary Disease * Asthmatic patient under inhaled corticoid therapy

Design outcomes

Primary

MeasureTime frameDescription
Snore Index3 monthsnumber of snores \>36 dB per hour of sleep by BresoDx

Secondary

MeasureTime frameDescription
Maximum sound of snoring/night3 months(dB), in supine, non-supine and both positions by BresoDx
Sleep time3 monthsTotal sleep time (h), in supine, non-supine and both positions by BresoDx
Apnoea Hypopnea Index3 months(AHI) Number of apnea/hypopnea per hour of sleep, in supine, non-supine and both positions by BresoDx
Orofacial functional score (NOT-S questionnaire)3 monthsUsing NOT-S questionnaire
Mean sound of snoring/night3 months(dB), in supine, non-supine and both positions by BresoDx
Quality of sleep3 monthsUsing Spiegel questionnaire
Comfort / Safety3 monthsUsing homemade questionnaire relative to TRP snorless TM
Nasal patency3 monthsMeasure of the Peak Nasal Inspiratory Flow by In-check PNIF meter
Treatment compliance3 monthsUsing the The TheraMon® temperature micro sensor
Tongue Endurance score3 monthsUsing IOPI medical device

Countries

Czechia

Contacts

Primary ContactFilip Bochníček, MuDr
fbochnicek@gmail.com+420 603 198 692

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026